Allurion Technologies Inc.

ALUR

US02008G1022

Software

Market Closed - Nyse Other stock markets 04:00:02 2024-05-21 pm EDT			5-day change	1st Jan Change
1.69 ^USD	0.00%		-19.91%	-54.81%

May. 14	Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q1 Revenue $9.4M, vs. Street Est of $9M	MT
May. 14	Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	CI

Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the First Quarter 2024

April 30, 2024 at 08:30 am EDT

Allurion Technologies Inc. provided preliminary earnings guidance for the first quarter 2024. for the quarter, the company expected revenue in the range of $9.2 million to $9.3 million, reflecting growth of between 12%-13% over the fourth quarter of 2023.

Latest news about Allurion Technologies Inc.

Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q1 Revenue $9.4M, vs. Street Est of $9M	May. 14	MT
Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	May. 14	CI
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the First Quarter 2024	Apr. 30	CI
Allurion Technologies Inc. announced that it has received $48 million in funding from RTW Investments, LP	Apr. 16	CI
Allurion Technologies Inc. amended terms of the transaction	Apr. 15	CI
Allurion Technologies Inc. announced that it expects to receive funding from RTW Investments, LP	Apr. 13	CI
Sector Update: Health Care Stocks Slump Late Afternoon	Apr. 04	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	Apr. 04	MT
Sector Update: Health Care	Apr. 04	MT
Top Midday Gainers	Apr. 04	MT
Allurion Technologies' Shares, Trading Volume Jump After US Launch of Weight-Loss System	Apr. 04	MT
Chardan Initiates Allurion Technologies With Buy Rating, Price Target is $5	Apr. 04	MT
Allurion Technologies, Inc. Expands Virtual Care Suite to the United States	Apr. 04	CI
Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q4 Revenue $8.2M	Mar. 21	MT
Allurion Technologies Inc. Reiterates Earnings Guidance for the Full Year 2024	Mar. 21	CI
Allurion Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Allurion Technologies Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 21	CI
Allurion Technologies Inc. Appoints Milena Alberti-Perez as Board of Directors as Audit Committee Chair	Mar. 12	CI
Jefferies Starts Allurion Technologies With Buy Rating, $5 Price Target	Feb. 09	MT
Allurion Technologies Inc. Appoints Brendan Gibbons as Its New Chief Legal Officer and Corporate Secretary	Jan. 29	CI
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss	Jan. 23	CI
Allurion Technologies, Inc.'s Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships	Jan. 17	CI
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year of 2023 and Full Year of 2024	Jan. 08	CI
Allurion Technologies Inc. Announces New Research Highlights the Positive Impact of GLP-1s and Other Anti-Obesity Medications on the Allurion Program	Jan. 05	CI
Allurion Technologies, Inc. Announces an Expanded Commercial Agreement with Weight Doctors	Jan. 02	CI

Chart Allurion Technologies Inc.

Duration

Period

More charts

Company Profile

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.

Sector

Software

Calendar

2024-11-10 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.69 USD

Average target price

5 USD

Spread / Average Target

+195.86%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
ALLURION TECHNOLOGIES INC.	-54.81%	81.03M
MICROSOFT CORPORATION	+14.09%	3,189B
SYNOPSYS INC.	+11.00%	87.18B
CADENCE DESIGN SYSTEMS, INC.	+6.51%	78.95B
DASSAULT SYSTÈMES SE	-10.73%	55.02B
PALANTIR TECHNOLOGIES INC.	+23.70%	47.3B
THE TRADE DESK, INC.	+32.92%	46.79B
ATLASSIAN CORPORATION	-25.15%	46.35B
SEA LIMITED	+80.89%	42.08B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-5.92%	25.86B

Other Software